Speaker illustration

Doctor Michael Gray

royal north shore hospital, Sydney (Australia)

Member of:

European Society of Cardiology

Mirabegron in peripheral vascular disease: the STAR-PAD trial.

Event: ESC Congress 2022

Topic: Pharmacology and Pharmacotherapy

Session: Beta3 adrenergic agonists in the clinic: the end of the beginning


This platform is supported by

logo Novo Nordisk